HUMATROPE Side Effects

6537116-X | Aplastic Anaemia
on Jan 07, 2010 Male patient from JAPAN , weighting 116.8 lb, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia. Humatrope dosage: Unk, Unk. Patient was hospitalized.

6530495-9 | Attention Deficit/hyperactivity Disorder, Csf Pressure Increased, Headache, Intracranial Pressure Increased, Muscle Spasticity, Toe Walking
Patient was taking Humatrope (View Usage). Patient had the following side effects: attention deficit/hyperactivity disorder, csf pressure increased, headache (What is headache?), intracranial pressure increased, muscle spasticity, toe walking on Dec 28, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 62.61 lb, was diagnosed with growth hormone deficiency and. Humatrope dosage: . During the same period patient was treated with GENOTROPIN (1.2 Mg, Daily (1/d)) (View Genotropin Review and Genotropin Label ), HUMAN GROWTH HORMONE (View Human Growth Hormone Review and Human Growth Hormone Label ).

6527132-6 | Arteriosclerosis Coronary Artery, Cardiovascular Disorder, Coronary Artery Disease, Myocardial Infarction
Adverse event was reported on Dec 28, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: 0.2 Mg, Daily (1/d)) was diagnosed with growth hormone deficiency and. Location: UNITED STATES , weighting 197.0 lb, After Humatrope was administered, patient had the following side effects: arteriosclerosis coronary artery, cardiovascular disorder, coronary artery disease (What is coronary artery disease?), myocardial infarction. Patient was hospitalized.

6527088-6 | Osteonecrosis
on Dec 24, 2009 Female patient from JAPAN , 14 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Humatrope dosage: .


6521119-5 | Sleep Apnoea Syndrome
on Dec 22, 2009 Female patient from JAPAN , child 3 years of age, was diagnosed with chondrodystrophy and was treated with Humatrope (View Usage). Patient had the following side effects: sleep apnoea syndrome. Humatrope dosage: .

6521113-4 | Sleep Apnoea Syndrome
Patient was taking Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: sleep apnoea syndrome on Dec 22, 2009 from JAPAN Additional patient health information: Female patient , child 3 years of age, was diagnosed with chondrodystrophy and. Humatrope dosage: .

6521112-2 | Sleep Apnoea Syndrome
Adverse event was reported on Dec 22, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: ) was diagnosed with chondrodystrophy and. Location: JAPAN , child 3 years of age, Patient experienced the following unwanted or unexpected effects: sleep apnoea syndrome.

6517788-6 | Type 1 Diabetes Mellitus
on Dec 16, 2009 Female patient from FRANCE , child 11 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). Patient had the following side effects: type 1 diabetes mellitus. Humatrope dosage: . Patient was hospitalized.

6507015-8 | Blood Pressure Increased, Burning Sensation, Dysgeusia, Hyperhidrosis
on Dec 11, 2009 Male patient from UNITED KINGDOM , 55 years of age, was diagnosed with hypopituitarism and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: blood pressure increased, burning sensation, dysgeusia, hyperhidrosis. Humatrope dosage: 10 Mg, Weekly (1/w). During the same period patient was treated with NEBIDO /00103107/ (View Nebido /00103107/ Review and Nebido /00103107/ Label ), ATORVASTATIN CALCIUM (80 Mg, Unk) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CLOPIDOGREL (75 Mg, Unk) (View Clopidogrel Review and Clopidogrel Label ), FENOFIBRATE (160 Mg, Unk) (View Fenofibrate Review and Fenofibrate Label ), METFORMIN HCL (3000 Mg, Unk) (View Metformin Hcl Review and Metformin Hcl Label ), MOVELAT /01178201/ (View Movelat /01178201/ Review and Movelat /01178201/ Label ), NOVOMIX /01475801/ (136 Iu, Unk) (View Novomix /01475801/ Review and Novomix /01475801/ Label ), ROSIGLITAZONE MALEATE (4 Mg, Unk) (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ).

6476491-1 | Sleep Apnoea Syndrome
Patient was taking Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: sleep apnoea syndrome on Nov 25, 2009 from JAPAN Additional patient health information: Female patient , child 3 years of age, was diagnosed with chondrodystrophy and. Humatrope dosage: .

6476489-3 | Sleep Apnoea Syndrome
Adverse event was reported on Nov 25, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: ) was diagnosed with chondrodystrophy and. Location: JAPAN , child 3 years of age, Patient had the following side effects: sleep apnoea syndrome.

6476488-1 | Sleep Apnoea Syndrome
on Nov 25, 2009 Female patient from JAPAN , child 3 years of age, was diagnosed with chondrodystrophy and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: sleep apnoea syndrome. Humatrope dosage: .

6476487-X | Osteonecrosis
on Nov 25, 2009 Female patient from JAPAN , 14 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Humatrope dosage: .

6475277-1 | Anaemia, Colon Cancer, Insulin-like Growth Factor Decreased
Patient was taking Humatrope (View Usage). Patient had the following side effects: anaemia, colon cancer, insulin-like growth factor decreased on May 28, 2009 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 122.0 lb, was diagnosed with hypopituitarism and. Humatrope dosage: 0.2 Mg, Qod.

6475173-X | Atrioventricular Block First Degree, Ischaemic Stroke
Adverse event was reported on Jul 10, 2009 by a Male patient taking Humatrope (View Usage) (Dosage: 0.3 Mg, Daily (1/d)) was diagnosed with hypopituitarism, blood pressure increased and. Location: UNITED STATES , 82 years of age, weighting 117.0 lb, After Humatrope was administered, patient had the following side effects: atrioventricular block first degree, ischaemic stroke. During the same period patient was treated with PREDNISONE (5 Mg, Daily (1/d)) (View Prednisone Review and Prednisone Label ), DESMOPRESSIN (0.1 Mg, Daily (1/d)) (View Desmopressin Review and Desmopressin Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

6475029-2 | Cardiac Arrest, Hypertrophic Cardiomyopathy, Hypokalaemia, Ventricular Fibrillation
on May 14, 2009 Male patient from UNITED STATES , weighting 146.0 lb, was diagnosed with body height below normal and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hypertrophic cardiomyopathy, hypokalaemia, ventricular fibrillation. Humatrope dosage: .

6474882-6 | Brain Oedema
on Feb 17, 2009 Female patient from ITALY , child 7 years of age, was treated with Humatrope (View Usage). Patient had the following side effects: brain oedema. Humatrope dosage: 5 Mg, Weekly (1/w) (15 Ui, 0.16mg/kg Per Week). During the same period patient was treated with CORTISONE (6 Mg, Daily (1/d)) (View Cortisone Review and Cortisone Label ).

6473503-6 | Hypernatraemia
Patient was taking Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: hypernatraemia on Oct 15, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 20 years of age, was diagnosed with growth hormone deficiency, diabetes insipidus (What is diabetes insipidus?), adrenal insufficiency and. Humatrope dosage: 0.3 Mg, Daily (1/d). During the same period patient was treated with DDAVP (20 Ug, 2/d) (View Ddavp Review and Ddavp Label ), HYDROCORTISONE (5 Mg, 2/d) (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (125 Ug, Daily (1/d)) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6473376-1 | Chronic Allograft Nephropathy, Renal Cell Carcinoma Stage Ii
Adverse event was reported on Dec 05, 2008 by a Male patient taking Humatrope (View Usage) (Dosage: ) was diagnosed with growth hormone deficiency and. Location: ITALY , 15 years of age, Patient experienced the following unwanted or unexpected effects: chronic allograft nephropathy, renal cell carcinoma stage ii. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

6473181-6 | Agitation, Depressed Mood, Fatigue, Hyperhidrosis, Malaise, Mental Impairment, Myocardial Infarction, Nervousness, Ocular Hyperaemia
on Jun 16, 2009 Male patient from UNITED STATES , weighting 133.0 lb, was diagnosed with growth hormone deficiency, type 1 diabetes mellitus, hypoglycaemic unconsciousness and was treated with Humatrope (View Usage). Patient had the following side effects: agitation, depressed mood, fatigue, hyperhidrosis, malaise, mental impairment, myocardial infarction, nervousness, ocular hyperaemia. Humatrope dosage: 0.4 Mg, Unk. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), GLUCAGON (Unk, As Needed) (View Glucagon Review and Glucagon Label ), INSULIN (View Insulin Review and Insulin Label ).

6472108-0 | Aphasia, Cerebellar Ataxia, Extrapyramidal Disorder, Hypotonia, No Therapeutic Response
on Apr 16, 2008 Male patient from FRANCE , child 8 years of age, was diagnosed with growth retardation and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: aphasia (What is aphasia?), cerebellar ataxia, extrapyramidal disorder, hypotonia, no therapeutic response. Humatrope dosage: 0.2 Mg/kg, Unk.

6472101-8 | Amnesia, Decreased Appetite, Hypotonia, No Therapeutic Response
Patient was taking Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, decreased appetite, hypotonia, no therapeutic response on Apr 16, 2008 from FRANCE Additional patient health information: Female patient , child 11 years of age, was diagnosed with body height below normal and. Humatrope dosage: .

6472094-3 | Cachexia, Diabetes Mellitus, Encephalopathy, Mental Retardation, Nephrotic Syndrome, Neurological Decompensation, No Therapeutic Response, Renal Failure, Retinogram Abnormal
Adverse event was reported on Apr 16, 2008 by a Male patient taking Humatrope (View Usage) (Dosage: 0.36 Mg/kg, Unk) was diagnosed with growth retardation and. Location: FRANCE , child 7 years of age, Patient had the following side effects: cachexia, diabetes mellitus, encephalopathy, mental retardation, nephrotic syndrome, neurological decompensation, no therapeutic response, renal failure, retinogram abnormal.

6471937-7 | Anaemia, Hyperlactacidaemia, Nervous System Disorder, No Therapeutic Response, Renal Tubular Disorder, Visual Acuity Reduced
on Apr 16, 2008 Female patient from FRANCE , child 6 years of age, was diagnosed with growth retardation and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: anaemia, hyperlactacidaemia, nervous system disorder, no therapeutic response, renal tubular disorder, visual acuity reduced. Humatrope dosage: 0.18 Mg/kg, Daily (1/d).

6471669-5 | Fear, Syncope
on Jul 21, 2008 Male patient from UNITED STATES , weighting 61.99 lb, was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: fear, syncope. Humatrope dosage: .

6471654-3 | Colon Cancer Metastatic
Patient was taking Humatrope (View Usage). Patient had the following side effects: colon cancer metastatic on Apr 21, 2008 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with prophylaxis and. Humatrope dosage: 0.6 Mg, 2/d. During the same period patient was treated with TESTOSTERONE (200 Mg, Weekly (1/w)) (View Testosterone Review and Testosterone Label ), DEHYDROEPIANDROSTERONE (100 Mg, Daily (1/d)) (View Dehydroepiandrosterone Review and Dehydroepiandrosterone Label ), PREDNISONE (6 Mg, Daily (1/d)) (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ).

6470929-1 | Brain Oedema, Hypersensitivity, Hypotension, Renal Failure
Adverse event was reported on Apr 21, 2008 by a Female patient taking Humatrope (View Usage) (Dosage: 0.1 Mg, Each Evening) was diagnosed with hypopituitarism, depression (What is depression?), hypothyroidism and. Location: UNITED STATES , 38 years of age, weighting 232.0 lb, After Humatrope was administered, patient had the following side effects: brain oedema, hypersensitivity, hypotension, renal failure. During the same period patient was treated with CALTRATE (View Caltrate Review and Caltrate Label ), SINGULAIR (View Singulair Review and Singulair Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), PAXIL (View Paxil Review and Paxil Label ), PHENERGAN HCL (25 Mg, As Needed) (View Phenergan Hcl Review and Phenergan Hcl Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6470150-7 | Abdominal Pain, Blood Cholesterol Increased, Decreased Appetite, Failure To Thrive, Femur Fracture, Hepatic Neoplasm Malignant Non-resectable, Liver Transplant, Nausea, Osteopenia
on Dec 06, 2007 Female patient from UNITED STATES , child 8 years of age, was diagnosed with turner's syndrome and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood cholesterol increased, decreased appetite, failure to thrive, femur fracture, hepatic neoplasm malignant non-resectable, liver transplant (What is liver transplant?), nausea (What is nausea?), osteopenia. Humatrope dosage: 0.05 Mg/kg, Unk.

6469284-2 | Epiphysiolysis, Hypogonadism
on May 21, 2008 Male patient from JAPAN , weighting 113.8 lb, was diagnosed with growth hormone deficiency, hypopituitarism and was treated with Humatrope (View Usage). Patient had the following side effects: epiphysiolysis, hypogonadism. Humatrope dosage: 1.2 Mg, Daily (1/d). During the same period patient was treated with CORTRIL (6 Mg, Each Morning) (View Cortril Review and Cortril Label ), THYRADIN (50 Mg, Daily (1/d)) (View Thyradin Review and Thyradin Label ), DESMOPRESSIN (0.05 Ml, 2/d) (View Desmopressin Review and Desmopressin Label ). Patient was hospitalized and became disabled.

6469080-6 | Abdominal Pain, Blood Urine Present, Chest Pain, Cough, Dysphagia, Ear Pain, Night Sweats, Pituitary Tumour Recurrent
Patient was taking Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood urine present, chest pain (What is chest pain?), cough, dysphagia, ear pain, night sweats, pituitary tumour recurrent on Oct 16, 2007 from UNITED STATES Additional patient health information: Female patient , 33 years of age, was diagnosed with hypopituitarism, hypothyroidism, multiple sclerosis (What is multiple sclerosis?), hypersomnia and. Humatrope dosage: . During the same period patient was treated with SYNTHROID (150 Ug, Daily (1/d)) (View Synthroid Review and Synthroid Label ), CYTOMEL (10 Ug, Daily (1/d)) (View Cytomel Review and Cytomel Label ), TESTOSTERONE (0.25 Unk, Daily (1/d)) (View Testosterone Review and Testosterone Label ), VIVELLE /00045401/ (Unk, 2/w) (View Vivelle /00045401/ Review and Vivelle /00045401/ Label ), NORETHINDRONE (10 Mg, Daily (1/d)) (View Norethindrone Review and Norethindrone Label ), PREDNISONE (7 Mg, Daily (1/d)) (View Prednisone Review and Prednisone Label ), COPAXONE (20 Mg, Daily (1/d)) (View Copaxone Review and Copaxone Label ), ADDERALL XR 10 (20 Mg, 2/d) (View Adderall Xr 10 Review and Adderall Xr 10 Label ).

6468944-7 | Pituitary Tumour Benign
Adverse event was reported on Jun 11, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: 0.2 Mg, Daily (1/d)) was diagnosed with growth hormone deficiency, adrenal insufficiency, secondary hypothyroidism, hypercholesterolaemia, essential hypertension and. Location: JAPAN , 72 years of age, Patient experienced the following unwanted or unexpected effects: pituitary tumour benign. During the same period patient was treated with CORTRIL (25 Mg, Daily (1/d)) (View Cortril Review and Cortril Label ), THYRADIN S (75 Ug, Daily (1/d)) (View Thyradin-s Review and Thyradin-s Label ), MEVALOTIN /JPN/ (10 Mg, Daily (1/d)) (View Mevalotin /jpn/ Review and Mevalotin /jpn/ Label ), BLOPRESS /GFR/ (4 Mg, Daily (1/d)) (View Blopress /gfr/ Review and Blopress /gfr/ Label ), NORVASC (5 Mg, Daily (1/d)) (View Norvasc Review and Norvasc Label ).

6468781-3 | Neoplasm Progression
on Apr 24, 2008 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). Patient had the following side effects: neoplasm progression. Humatrope dosage: .

6435253-1 | Abdominal Pain, Benign Intracranial Hypertension, Constipation, Diarrhoea, Gynaecomastia, Hallucination, Thymus Disorder
on Oct 30, 2009 Male patient from UNITED STATES , weighting 35.17 lb, was diagnosed with hypothalamo-pituitary disorder, hypothyroidism, adrenal insufficiency and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), benign intracranial hypertension, constipation (What is constipation?), diarrhoea, gynaecomastia, hallucination, thymus disorder. Humatrope dosage: 0.3 Mg, 6/w. During the same period patient was treated with LEVOXYL (25 Ug, Daily (1/d)) (View Levoxyl Review and Levoxyl Label ), CORTEF /00028604/ (6.25 Mg, Daily (1/d)) (View Cortef /00028604/ Review and Cortef /00028604/ Label ).

6430459-X | Breast Pain
Patient was taking Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: breast pain on Oct 26, 2009 from TURKEY Additional patient health information: Female patient , 18 years of age, was diagnosed with growth hormone deficiency and. Humatrope dosage: .

6428127-3 | Hyperglycaemia, Increased Appetite, Insulin Resistance, Off Label Use, Prader-willi Syndrome, Urinary Tract Infection, Weight Increased
Adverse event was reported on Oct 27, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 315.0 lb, Patient had the following side effects: hyperglycaemia, increased appetite, insulin resistance, off label use, prader-willi syndrome (What is prader-willi syndrome?), urinary tract infection (What is urinary tract infection?), weight increased. During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), NOVOLOG (View Novolog Review and Novolog Label ), METFORMIN (View Metformin Review and Metformin Label ), LEVEMIR (View Levemir Review and Levemir Label ), ALTACE (View Altace Review and Altace Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), GEODON (20 Mg, Each Morning) (View Geodon Review and Geodon Label ). Patient was hospitalized.

6426655-8 | Oedema Peripheral, Pain In Extremity
on Oct 23, 2009 Male patient from TURKEY , 15 years of age, was diagnosed with blood growth hormone decreased and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: oedema peripheral, pain in extremity. Humatrope dosage: 12 Mg, Daily (1/d). Patient was hospitalized.

6413053-6 | Sleep Apnoea Syndrome
on Oct 23, 2009 Female patient from UNITED STATES , weighting 210.0 lb, was diagnosed with blood growth hormone decreased, fibromyalgia and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: sleep apnoea syndrome. Humatrope dosage: 1 Click To 7 Clicks Over 6 Years. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), AMBIEN (View Ambien Review and Ambien Label ), PAXIL (View Paxil Review and Paxil Label ), XANAX (View Xanax Review and Xanax Label ), PHENTERMINE HYDROCHLORIDE (View Phentermine Hydrochloride Review and Phentermine Hydrochloride Label ), GLUCAPHAGE (View Glucaphage Review and Glucaphage Label ), ELAVIL (View Elavil Review and Elavil Label ). Patient was hospitalized.

6393109-7 | Aplastic Anaemia
Patient was taking Humatrope (View Usage). Patient had the following side effects: aplastic anaemia on Sep 28, 2009 from JAPAN Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with growth hormone deficiency and. Humatrope dosage: Unk, Unk. Patient was hospitalized.

6383495-6 | Confusional State, Dysarthria, Headache, Irritability, Paraesthesia
Adverse event was reported on Sep 23, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: ) . Location: SPAIN , child 10 years of age, After Humatrope was administered, patient had the following side effects: confusional state, dysarthria, headache (What is headache?), irritability, paraesthesia. Patient was hospitalized.

6377825-9 | Adrenocortical Carcinoma, Vaginal Haemorrhage
on Sep 18, 2009 Female patient from UNITED STATES , weighting 115.6 lb, was diagnosed with turner's syndrome and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: adrenocortical carcinoma, vaginal haemorrhage. Humatrope dosage: 2.4 Mg, Daily (1/d).

6375831-1 | Abnormal Behaviour, Depressed Level Of Consciousness, Fall, Partial Seizures, Road Traffic Accident
on Sep 16, 2009 Female patient from UNITED STATES , 60 years of age, was treated with Humatrope (View Usage). Patient had the following side effects: abnormal behaviour, depressed level of consciousness, fall (What is fall?), partial seizures, road traffic accident. Humatrope dosage: Unk, Unk 3 Clicks. During the same period patient was treated with ACTOS /AUS/ (View Actos /aus/ Review and Actos /aus/ Label ).

6362118-6 | Anaphylactic Shock
Patient was taking Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: anaphylactic shock on Sep 11, 2009 from UNITED KINGDOM Additional patient health information: Female patient , child 11 years of age, weighting 101.4 lb, was diagnosed with turner's syndrome and. Humatrope dosage: 1.6 Mg, Daily (1/d).

6354703-2 | Aplastic Anaemia
Adverse event was reported on Sep 09, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: ) was diagnosed with growth hormone deficiency and. Location: JAPAN , 14 years of age, Patient experienced the following unwanted or unexpected effects: aplastic anaemia. Patient was hospitalized.

6347425-5 | Pneumonia
on Aug 31, 2009 Female patient from UNITED STATES , child 6 years of age, was treated with Humatrope (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Humatrope dosage: . Patient was hospitalized.

6342406-X | Disseminated Intravascular Coagulation, Ileus, Sepsis
on Aug 25, 2009 Male patient from JAPAN , 70 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: disseminated intravascular coagulation, ileus, sepsis (What is sepsis?). Humatrope dosage: . Patient was hospitalized.

6341558-5 | Pancreatitis Acute
Patient was taking Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute on Aug 24, 2009 from ITALY Additional patient health information: Female patient , 13 years of age, weighting 151.7 lb, . Humatrope dosage: 0.033 Mg/kg, Daily (1/d) Divided Into 6 Weekly Doses. During the same period patient was treated with LEVOTHYROXINE SODIUM (According To Body Surface) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (According To Body Surface) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6339358-5 | Yellow Skin
Adverse event was reported on Aug 21, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: 3 U, Daily (1/d)) was diagnosed with growth hormone deficiency and. Location: INDIA , child 6 years of age, Patient had the following side effects: yellow skin.

6334042-6 | Osteoporosis
on Aug 20, 2009 Female patient from UNITED STATES , child 3 years of age, was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: osteoporosis (What is osteoporosis?). Humatrope dosage: . During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ).

6329473-4 | Pneumonia
on Aug 17, 2009 Female patient from UNITED STATES , child 6 years of age, was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). Humatrope dosage: . Patient was hospitalized.

6327577-3 | Blood Thyroid Stimulating Hormone Increased, Epiphyseal Fracture, Epiphysiolysis, Injury
Patient was taking Humatrope (View Usage). Patient had the following side effects: blood thyroid stimulating hormone increased, epiphyseal fracture, epiphysiolysis, injury on Aug 18, 2009 from UNITED STATES Additional patient health information: Male patient , 13 years of age, was diagnosed with body height below normal, blood thyroid stimulating hormone increased and. Humatrope dosage: . During the same period patient was treated with SYNTHROID (25 Ug, Daily (1/d)) (View Synthroid Review and Synthroid Label ).